Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...